HR. 2542In Committee
Old Drugs, New Cures Act
Exempts certain older drug reformulations from specialized Medicaid and Medicare rebate rules when they are designated as priority research drugs for new uses
Plain-English overview
What this bill does
Exempts certain older drug reformulations from specialized Medicaid and Medicare rebate rules when they are designated as priority research drugs for new uses
Key points
- Allow priority research drug designation
- Exempt designated drugs from rebates
Current status
Where it stands
Status
In Committee
Latest action
2025-04-01 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedHealth